Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 29Pain, Postoperative 10Colorectal Neoplasms 10Neoplasms 8Brain Neoplasms 8Stomach Neoplasms 7Prostatic Neoplasms 6Lung Neoplasms 6Pancreatic Neoplasms 5Melanoma 5Ovarian Neoplasms 4Hemorrhage 4Head and Neck Neoplasms 4Agnosia 4Rectal Neoplasms 3Neurotoxicity Syndromes 3Nasopharyngeal Carcinoma 3Myoma 3Multiple Endocrine Neoplasia Type 1 3Meningioma 3Lymphoma, Non-Hodgkin 3Leiomyoma 3Glioblastoma 3Delirium 3Colonic Neoplasms 3Chronic Pain 3Warts 2Uterine Cervical Neoplasms 2Stomatitis 2Skin Neoplasms 2

Interventions

Amiodarone 3Standard of Care 1Sodium Chloride 1Metoprolol 1Losartan 1Heparin, Low-Molecular-Weight 1Gonadal Steroid Hormones 1Electrocardiography 1Cardiac Surgical Procedures 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Atrial Fibrillation × Sodium Chloride × Clear all
NCT06067438 2026-05-22

Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer

OHSU Knight Cancer Institute

Phase 2 Recruiting
90 enrolled
Gastrointestinal

Atrial Fibrillation, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡